StockData
Accendra Health Inc logo

Accendra Health Inc (ACCH) stock

ACCHWholesale-Medical, Dental & Hospital Equipment & SuppliesFiscal year ends December 31Also trades as ACH
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 1/30
Share price
Not available yet

Price, market cap and P/E appear here once daily prices are connected.

Accendra Health free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Accendra Health's free cash flow for the twelve months ending Sep 30, 2026 was -$199.12M. For fiscal 2025 it was -$292.75M. The highest annual figure on record is $568.34M in fiscal 2023.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$292.75M–
FY2024Dec 31, 2024-$8.79M-101.5%
FY2023Dec 31, 2023$568.34M+240.5%
FY2022Dec 31, 2022$166.92M+100.6%
FY2021Dec 31, 2021$83.19M-71.2%
FY2020Dec 31, 2020$288.80M+133.5%
FY2019Dec 31, 2019$123.67M+74.9%
FY2018Dec 31, 2018$70.72M+219.1%
FY2017Dec 31, 2017$22.16M-86.8%
FY2016Dec 31, 2016$167.39M-33.0%
FY2015Dec 31, 2015$249.71M–
FY2014Dec 31, 2014-$52.19M-146.4%
FY2013Dec 31, 2013$112.44M-46.1%
FY2012Dec 31, 2012$208.67M+380.4%
FY2011Dec 31, 2011$43.44M-61.2%
FY2010Dec 31, 2010$111.96M-43.5%
FY2009Dec 31, 2009$198.29M+338.6%
FY2008Dec 31, 2008$45.21M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$56.58M–
Q2 FY2026Jun 30, 2026-$73.59M–
Q1 FY2026Mar 31, 2026-$91.72M–
Q4 FY2025Dec 31, 2025$22.77M-53.3%
Q3 FY2025Sep 30, 2025-$214.65M–
Q2 FY2025Jun 30, 2025-$20.01M-128.4%
Q1 FY2025Mar 31, 2025-$80.86M–
Q4 FY2024Dec 31, 2024$48.75M-39.0%
Q3 FY2024Sep 30, 2024-$34.21M-132.0%
Q2 FY2024Jun 30, 2024$70.35M-73.3%
Q1 FY2024Mar 31, 2024-$98.96M-188.2%
Q4 FY2023Dec 31, 2023$79.87M+109.4%
Q3 FY2023Sep 30, 2023$106.85M+460.2%
Q2 FY2023Jun 30, 2023$263.62M+651.3%
Q1 FY2023Mar 31, 2023$112.25M+60.1%
Q4 FY2022Dec 31, 2022$38.15M+6.5%
Q3 FY2022Sep 30, 2022$19.07M-59.8%
Q2 FY2022Jun 30, 2022$35.09M–
Q1 FY2022Mar 31, 2022$70.09M+244.0%
Q4 FY2021Dec 31, 2021$35.80M-15.3%
Q3 FY2021Sep 30, 2021$47.49M-54.1%
Q2 FY2021Jun 30, 2021-$25.08M-149.6%
Q1 FY2021Mar 31, 2021$20.38M-77.0%
Q4 FY2020Dec 31, 2020$42.28M+167.9%
Q3 FY2020Sep 30, 2020$103.50M+6.2%
Q2 FY2020Jun 30, 2020$50.57M-35.7%
Q1 FY2020Mar 31, 2020$88.68M–
Q4 FY2019Dec 31, 2019$15.79M–
Q3 FY2019Sep 30, 2019$97.47M+65.2%
Q2 FY2019Jun 30, 2019$78.67M+550.9%
Q1 FY2019Mar 31, 2019-$72.58M-748.1%
Q4 FY2018Dec 31, 2018-$19.30M-146.5%
Q3 FY2018Sep 30, 2018$59.01M-21.0%
Q2 FY2018Jun 30, 2018$12.09M–
Q1 FY2018Mar 31, 2018$11.20M–
Q4 FY2017Dec 31, 2017$41.48M+13.4%
Q3 FY2017Sep 30, 2017$74.65M–
Q2 FY2017Jun 30, 2017-$65.66M–
Q1 FY2017Mar 31, 2017-$36.51M–
Q4 FY2016Dec 31, 2016$36.56M–

More Accendra Health figures

See a number that looks wrong?